Lung Cancer Biorepository Clinical Trials in Oklahoma City, OK

Lung cancer biorepository clinical trials in Oklahoma City, OK, aim to advance research for future cancer treatments.

Lung Cancer Blood Test Research

Lung cancer continues to be a significant health concern, but in Oklahoma City, hope is growing through advanced research. Hightower Clinical is leading innovative lung cancer biorepository trials, contributing to future breakthroughs in treatment. Discover our lung cancer biorepository clinical trials today.

Cancer Clinical Trials & Colorectal Biomarker Clinical Trials

At Hightower Clinical, one of our studies aims to examine how different types of videos about colorectal cancer (CRC) screening influence screening rates and adherence to guidelines over time. Participants aged 45 to 70, due for a colonoscopy or other CRC screening, will be randomly assigned to one of three groups.

Additionally, blood and tissue samples will be collected to study biomarkers—key indicators that may help predict cancer risk or detect cancer earlier. This research could lead to improved cancer screening tests in the future.

Enroll Now

Age

45 to 70 Y and 18 Y and above

Gender

Male/Female

Condition

Cancer biorepository

Current Status

Recruiting

Location

Oklahoma

Study Information

Cancer Bio Repository

Study NameProtocol NumberSponsor
Cancer Bio Repository

2019-02 COMPASS

Exact Sciences

2021-05

Exact Sciences

HH-PRT-0005

Harbinger Health

Non-small Cell Lung Cancer – Biorepository

Hightower is conducting a non-interventional NSCLC biorepository study in Oklahoma City, OK, using longitudinal blood collection. The study collects clinical and molecular data from NSCLC patients throughout their standard treatment and monitoring. Blood samples are taken over time to track disease progression and explore how changes in ctDNA can help predict recurrence and treatment outcomes. Participation is free, with no insurance required. The study doctor will guide participants through the process and answer any questions to help them make an informed decision.

Enroll Now

Age

18 Years and older (Adult, Older Adult)

Gender

All

Condition

Non-Small Cell Lung Cancer

Current Status

Recruiting

Location

Oklahoma

Study Information

Non-Small Cell Lung Cancer

Study NameProtocol NumberSponsor
Non-Small Cell Lung Cancer

GEMINI – TP-CA-002

Tempus